- Home
- Science News
- Contributory Risk and Management of Comorbidities of Hypertension Obesity Diabetes Mellitus
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure
Published: October 31, 2016
- Hypertension, obesity, diabetes, hyperlipidemia, and metabolic syndrome are common comorbidities in heart failure (HF). This statement summarizes and provides guidance for managing these in association with HF.
- All of these are associated with the development of incident heart failure; however, the role of these in persons with chronic HF is unpredictable and management is challenging.
- This scientific statement explores these five comorbidities using an evidence-based approach and discusses how to manage them.
Supporting Materials
- Commentary: Non-Paradoxical Paradoxes of Heart Failure by Maya Guglin, MD, PhD
- Top Things to Know: Top Things to Know
Recommended Reading
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideline and the HF Society of America
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- Drugs That May Cause or Exacerbate Heart Failure
- Transitions of Care Heart Failure
- Forecasting the Impact of Heart Failure in the United States: A Policy Statement from the American Heart Association
- Heart Disease and Stroke Statistics 2016